Metabolix Company Profile (NASDAQ:MBLX)

About Metabolix

Metabolix logoMetabolix, Inc. is an advanced biomaterials company. The Company operates through the business of developing and commercializing technologies for the production of polymers and chemicals in microbes and plants segment. The Company is focused on delivering solutions to the plastics industry. The Company has its operations in the microbial genetics, fermentation process engineering, chemical engineering, polymer science, plant genetics and botanical science. The Company is focused on a family of biopolymers found in nature called polyhydroxyalkanoates (PHAs), which occur naturally in living organisms and are chemically similar to polyesters. The Company is also focusing on applications where the performance, biodegradability, biocontent and other attributes of its PHA biopolymers provide functional advantages, such as biodegradation, required by such applications, including PHA resins for molded articles and films, as well as PHA latex and other PHA coatings for paper and cardboard.

Industry, Sector and Symbol:
  • Sector: Industrial Products
  • Industry: Specialty Chemicals
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: MBLX
  • CUSIP:
Key Metrics:
  • Previous Close: $0.46
  • 50 Day Moving Average: $0.63
  • 200 Day Moving Average: $1.19
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.21
  • P/E Growth: 0.00
  • Market Cap: $12.81M
  • Outstanding Shares: 27,844,000
  • Beta: 3.17
Additional Links:
Companies Related to Metabolix:

Analyst Ratings

Consensus Ratings for Metabolix (NASDAQ:MBLX) (?)
Ratings Breakdown: 2 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $3.00 (552.17% upside)

Analysts' Ratings History for Metabolix (NASDAQ:MBLX)
DateFirmActionRatingPrice TargetDetails
2/9/2016HC WainwrightReiterated RatingBuyView Rating Details
2/9/2016Rodman & RenshawInitiated CoverageBuy$3.00View Rating Details
1/15/2015Jefferies GroupReiterated RatingHold$0.75 -> $0.50View Rating Details
(Data available from 8/23/2014 forward)


Earnings History for Metabolix (NASDAQ:MBLX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/11/2016Q1($0.23)($0.24)ViewN/AView Earnings Details
3/29/2016Q415($0.24)($0.22)$870.00 millionViewListenView Earnings Details
11/10/2015Q315($0.26)($0.22)ViewListenView Earnings Details
8/12/2015Q215($0.26)ViewListenView Earnings Details
5/13/2015Q115($0.04)($0.04)ViewListenView Earnings Details
3/19/2015Q414($0.09)($0.05)ViewListenView Earnings Details
11/5/2014Q3 14($0.16)($0.14)ViewListenView Earnings Details
8/6/2014($0.23)($0.21)ViewN/AView Earnings Details
5/14/2014($0.21)($0.23)ViewN/AView Earnings Details
3/27/2014($0.21)($0.25)ViewN/AView Earnings Details
11/5/2013Q3 13($0.24)($0.21)ViewN/AView Earnings Details
7/31/2013Q2 2013($0.20)($0.23)$1.57 millionViewN/AView Earnings Details
5/8/2013Q1 2013($0.25)($0.20)$1.43 million$1.94 millionViewN/AView Earnings Details
3/26/2013Q4 2012($0.26)($0.28)$1.23 million$1.40 millionViewN/AView Earnings Details
11/1/2012($0.24)($0.23)ViewN/AView Earnings Details
7/26/2012($0.26)($0.23)ViewN/AView Earnings Details
4/26/2012$0.84$0.84ViewN/AView Earnings Details
3/6/2012($0.30)($0.28)ViewN/AView Earnings Details
11/1/2011($0.29)($0.28)ViewN/AView Earnings Details
7/27/2011($0.33)($0.33)ViewN/AView Earnings Details
4/27/2011($0.36)($0.36)ViewN/AView Earnings Details
3/9/2011($0.37)($0.35)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Metabolix (NASDAQ:MBLX)
Current Year EPS Consensus Estimate: $-0.22 EPS
Next Year EPS Consensus Estimate: $-0.38 EPS


Dividend History for Metabolix (NASDAQ:MBLX)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Metabolix (NASDAQ:MBLX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/17/2015William P ScullyMajor ShareholderBuy31,833$2.11$67,167.63View SEC Filing  
9/15/2015William P. Scullymajor shareholderBuy67,500$2.16$145,800.00View SEC Filing  
9/10/2015William P ScullyMajor ShareholderBuy25,000$2.71$67,750.00View SEC Filing  
9/8/2015William P ScullyMajor ShareholderBuy40,000$2.23$89,200.00View SEC Filing  
9/4/2015William P. Scullymajor shareholderBuy42,750$2.15$91,912.50View SEC Filing  
8/28/2015William P ScullyMajor ShareholderBuy26,600$1.99$52,934.00View SEC Filing  
6/19/2015Birchview Capital Gp, LlcDirectorBuy43,700$3.32$145,084.00View SEC Filing  
6/19/2015Family Foundation SchulerMajor ShareholderBuy1,664,840$3.32$5,527,268.80View SEC Filing  
6/19/2015Joseph H ShaulsonCEOBuy35,000$3.32$116,200.00View SEC Filing  
6/19/2015Lynne H BrumVPBuy14,570$3.32$48,372.40View SEC Filing  
6/19/2015Walsem Johan VanCOOBuy12,000$3.32$39,840.00View SEC Filing  
11/29/2013Matthew StrobeckDirectorBuy100,000$1.00$100,000.00View SEC Filing  
12/3/2012Richard P EnoCEOBuy20,000$1.17$23,400.00View SEC Filing  
11/30/2012Nostrand Robert L VanDirectorBuy20,000$1.07$21,400.00View SEC Filing  
11/30/2012Oliver P PeoplesVPBuy40,000$1.07$42,800.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Metabolix (NASDAQ:MBLX)
DateHeadline logoMetabolix (MBLX) Enters LOI to Sell Biopolymer Assets in $10M Deal (NASDAQ:MBLX) - August 22 at 6:04 PM logoMETABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial S (NASDAQ:MBLX) - August 22 at 6:04 PM logoMetabolix Announces $10 Million Binding Letter of Intent for Sale of Biopolymer Assets to CJ CheilJedang (NASDAQ:MBLX) - August 22 at 6:04 PM logoMETABOLIX, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities (NASDAQ:MBLX) - July 26 at 4:09 PM logo4:06 pm Metabolix announces restructuring under which Yield10 Bioscience will become its core business; will reduce ~half of its workforce; shares halted (NASDAQ:MBLX) - July 21 at 4:06 PM logoMetabolix Announces New Strategic Direction: Yield10 Bioscience to Become Core Business, Biopolymers Operations to be Wound Down (NASDAQ:MBLX) - July 21 at 4:05 PM logoMetabolix (MBLX) Receives Delisting Notification; Says in Talks with 'Interested Parties' (NASDAQ:MBLX) - July 7 at 6:08 PM logoMETABOLIX, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T (NASDAQ:MBLX) - July 7 at 4:12 PM logoETF’s with exposure to Metabolix, Inc. : June 23, 2016 (NASDAQ:MBLX) - June 23 at 1:44 PM logoMetabolix, Inc. :MBLX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016 (NASDAQ:MBLX) - June 22 at 12:36 PM
News IconPerformance at a Glance on Metabolix, Inc. (NASDAQ:MBLX) - HNN (NASDAQ:MBLX) - May 30 at 6:52 PM logoStrong Sell Calls Count For Metabolix, Inc. (NASDAQ:MBLX) At 0 - Investor Newswire (NASDAQ:MBLX) - May 30 at 6:52 PM logoMETABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Submission of Matters to a Vote of Se (NASDAQ:MBLX) - May 19 at 4:04 PM logoMetabolix Raises $2 Million in Amendment to Licensing Deal with Tepha (NASDAQ:MBLX) - May 18 at 9:52 AM logoMetabolix Evaluating Strategic Alternatives for its Specialty PHA Biopolymers Business and Yield10 Bioscience Program (NASDAQ:MBLX) - May 16 at 4:52 PM logoMetabolix to Highlight Mirel PHA Biopolymers in Packaging Applications at SustPack 2016 (NASDAQ:MBLX) - April 7 at 9:13 AM logoEdited Transcript of MBLX earnings conference call or presentation 29-Mar-16 8:30pm GMT (NASDAQ:MBLX) - March 30 at 12:56 PM logoMetabolix Announces Fourth Quarter and Full Year 2015 Financial Results (NASDAQ:MBLX) - March 29 at 4:24 PM logoMetabolix Signs MOU with CJ CheilJedang for Strategic Commercial Manufacturing Arrangement (NASDAQ:MBLX) - March 29 at 4:24 PM logoMETABOLIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, Financial Statements (NASDAQ:MBLX) - March 29 at 4:12 PM logoMetabolix : Announces Formation of Scientific Advisory Board for Yield10 Bioscience; Names Danny Schnell, Ph.D. and Michael Lassner, Ph.D, as Members (NASDAQ:MBLX) - February 26 at 2:26 PM logoMetabolix Announces Formation of Scientific Advisory Board for Yield10 Bioscience (NASDAQ:MBLX) - February 24 at 9:00 AM logoMetabolix to Provide Company Update at Source Capital Conference (NASDAQ:MBLX) - February 10 at 9:05 AM logoCoverage initiated on Metabolix by Rodman & Renshaw (NASDAQ:MBLX) - February 9 at 7:04 AM logoMetabolix to Present at Source Capital Conference (NASDAQ:MBLX) - February 4 at 4:05 PM logoBiomaterials firm Metabolix to move HQ to Woburn from Cambridge (NASDAQ:MBLX) - January 27 at 2:18 PM logoMetabolix to Relocate Corporate Headquarters to Woburn, Massachusetts in 2016 (NASDAQ:MBLX) - January 26 at 4:22 PM logoMETABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definitive (NASDAQ:MBLX) - January 26 at 4:11 PM logoMetabolix, Inc. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:MBLX) - December 16 at 2:51 PM logoMETABOLIX, INC. Financials (NASDAQ:MBLX) - December 8 at 1:17 PM logoMetabolix to Present at the LD Micro Main Event (NASDAQ:MBLX) - November 23 at 4:05 PM logoMETABOLIX, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:MBLX) - November 12 at 2:55 PM logoMetabolix Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:MBLX) - November 10 at 4:30 PM logoMetabolix Announces Third Quarter 2015 Financial Results (NASDAQ:MBLX) - November 10 at 4:16 PM logoMETABOLIX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:MBLX) - November 10 at 4:13 PM logoQ3 2015 Metabolix Inc Earnings Release - After Market Close (NASDAQ:MBLX) - November 10 at 7:07 AM logoMetabolix to Present at Drexel Hamilton Conference (NASDAQ:MBLX) - October 30 at 9:15 AM logoMetabolix to Conduct Webcast of Its Third Quarter 2015 Earnings Call (NASDAQ:MBLX) - October 27 at 9:37 AM logoMetabolix Signs Global, Exclusive Distribution Agreement With Kolar Filtration (NASDAQ:MBLX) - October 15 at 9:12 AM logoMETABOLIX, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securitie (NASDAQ:MBLX) - October 7 at 5:18 PM


Metabolix (NASDAQ:MBLX) Chart for Tuesday, August, 23, 2016

Last Updated on 8/23/2016 by Staff